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Abstract The association between estrogens ‘‘with-
drawal’’ and attacks of migraine without aura is well-known.
The aim of the study was to examine the features of laser
evoked potentials (LEPs), including habituation, in women
suffering from migraine without aura versus healthy con-
trols, during the pre-menstrual and late luteal phases. Nine
migraine without aura and 10 non-migraine healthy women,
were evaluated during the pre-menstrual phase and late luteal
phase. The LEPs were recorded during the inter-critical
phase. The right supraorbital zone and the dorsum of the right
hand were stimulated. Three consecutive series of 20 laser
stimuli were obtained for each stimulation site. Laser pain
perception was rated by a 0–100 VAS after each stimulation
series. Migraine patients exhibited increased LEPs ampli-
tude and reduced habituation compared to normal subjects.
Laser-pain perception was increased during the pre-men-
strual phase in both patients and controls. Migraine patients
and controls showed increased P2 and N2–P2 amplitude in
the pre-menstrual phase, on both stimulation sites. During
the pre-menstrual phase the N2–P2 habituation appeared to
be reduced in both migraine and healthy women. The
estrogen withdrawal occurring during the menstrual cycle
may favor reduced habituation of nociceptive cortex, which
may facilitate pain symptoms and migraine in predisposed
women.
Keywords Migraine  Menstrual cycle  Pain sensitivity 
Laser evoked potentials
Introduction
Women suffer a disproportionate amount of pain during their
lifetime compared to men. Over the past 15 years, a growing
number of studies have suggested several causes for this sex
difference, ranging from cellular to psychosocial levels of
analysis [1]. Migraine, an incapacitating disorder based on
altered neuronal excitability [2–4], is three times more
common in women during reproductive years than in men of
a similar age [5]. Initial evidence for the role of estrogen in
migraine headache stems from studies, published in the early
1970s [6], which evaluated the influence of exogenous
estrogens on women prone to migraine around the time of
menses. Indeed, migraine attacks were correlated with
declining plasma estradiol levels [6]. This was particularly
evident after prolonged estradiol elevations, as those
observed before menses [7–9]. However, estrogenic modu-
lation of pain per se is a complex phenomenon, since estro-
gens may have either a pro- or an anti-nociceptive effect [1].
There is neurophysiologic evidence about the role of men-
strual cycle in increasing the probability of migraine attacks,
based on the amplitude changes of an event-related poten-
tials—the contingent negative variation (CNV),—whose
abnormalities have been referred to the neuronal factors
predisposing to migraine [10, 11]. In a recent study about
pain sensations to the cold presser test in normally
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menstruating women, pain threshold was found reduced
during the late luteal phase compared with the pre-menstrual
phase [12]. However, other studies on pain thresholds during
the menstrual cycle reported uncertain results in healthy [13]
and fibromyalgia suffering women [14].
The majority of evoked and event-related potentials
studies in migraine have shown two abnormalities: increased
amplitudes of averages of large numbers of trials and lack of
habituation in successive trial blocks during the pain-free
phase, with the ictal normalization of evoked potential
amplitudes and habituation [15]. The evoked potentials
amplitude is a quantitative index of the neuronal population
activated by certain sensory inputs; it tends to decrease
during repetitive sensory stimulation, as the expression of a
progressive reduction of the neuronal response. The physi-
ologic phenomenon of a sensory cortex, which progressively
reduces its activity in being reached by repetitive stimuli, is
known as habituation. According to the definition by
Thompson and Spencer [16], the habituation is a phenome-
non of decrement in the amplitude of sensory cortical
responses to repeated presentations of similar stimuli,
excluding receptor or effectors fatigue, in order to avoid
brain over-stimulation.
There is growing evidence about the utility of laser
evoked potentials (LEPs) in the clinical management of
primary headaches [17]. In migraine, during the interictal
phase, LEPs have normal amplitudes in basal conditions,
but they show a reduced habituation to repetitive stimuli
and an altered modulation by attention tasks [18–20].
During the migraine attack, LEPs are enhanced and laser-
pain perception is increased, suggesting central sensitiza-
tion phenomena [21], which may subtend the persistence of
reduced habituation pattern to repetitive nociceptive stim-
uli [20]. LEPs may provide an objective measurement of
cortical pain processing during the different phases of
menstrual cycle in both healthy and migraine women.
The aim of the study was to evaluate pain perception
and brain responses to laser stimuli during the late luteal
versus pre-menstrual phase in normally menstruating
migraine without aura patients and in non-migraine healthy
women. In addition, also the LEP habituation to repetitive
series of stimulations was investigated.
Methods
Subjects
The study design planned the selection of normally men-
struating women suffering from migraine without aura
among the patients coming to the Neurophysiopathology of
Pain Unit of the Neurological and Psychiatric Sciences
Department of Bari University. They were compared to
normally menstruating non migraine healthy subjects,
selected among the medical and technical staff. The diag-
nosis was made according to the criteria of the Interna-
tional Headache Society (code 1.1) [22] by the first author
(neurologist) trained in diagnosis and treatment of head-
aches. Before being included in the study, all migraineurs
and controls were asked to keep a headache diary and a
diary of the menstrual cycle for 3 months in order to collect
clinical data and, for patients, to assess the relationship
between migraine and menstruation. The exclusion criteria
were similar for both groups and included the following
ones: consumption of central nervous system acting drugs
in the last 3 months, history of psychopathological or
neurological disorders, major medical problems, and oral
contraceptive drugs therapy in the last 3 months.
Migraineurs should not have used prophylactic migraine
medication for at least 3 months prior to the investigation,
nor triptans or analgesics in the 72 h preceding the
recording session. Migraine patients were examined in the
asymptomatic condition, at least 72 h following the last
attack and in the 48 h preceding the next one. In the course
of the study, we observed that this latter criterion was quite
impossible to be satisfied in all cases because of the early
occurrence of migraine attack after the pre-menstrual phase
recording session. Thus, we decided to tolerate an interval
C24 h following the experimental trial. The Ethics Com-
mittee of the Bari Policlinico General Hospital approved
the study. The subjects were informed about the course of
the experiment and gave written informed consent
according to the Helsinki Declaration. Among 20 initially
selected migraineurs without aura, only nine satisfied the
requested criteria. In fact, six patients were excluded
because a migraine attack occurred less than 24 h after the
LEPs recording session, three patients experienced head-
ache in the 72 h preceding the task, while two patients did
not give full cooperation to complete the study. The
included patients were all affected by menstrual-related
migraine without aura, according to the proposed sub-
classification of the International headache society [22].
Migraine women were 26 ± 6.8 years old, with mean
migraine duration of 9.8 ± 4.1 years and a mean headache
frequency 4 ± 2.94 days with headache/month in the last
3 months. We also selected 15 non-migraine normally
menstruating healthy subjects, but only 10 completed the
study, while five controls were lost to one of the recording
session, one for pregnancy, two for non-compliance, two
for an occurrence of menstrual cycle later than 2 days after
the LEP recording. They were 26.8 ± 5.3 years old.
Experimental design
In each subject, LEP recordings were performed in the
premenstrual and late-luteal phases of the menstrual cycle.
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A rise in the basal body temperature (BBT) was used to
confirm the ovulation occurrence. For this purpose, patients
were given basal thermometers and charts for recording
BBT. The onset of the next menses was estimated by
information supplied by patients relating to the length of
the last three menstrual cycles and the observation of a 0.3–
0.5C rise in BBT. In all subjects recordings were carried
out 14 ± 0.74 days and 1–2 days before the occurrence of
menstruation. The mean length of the menstrual cycle was
27.45 ± 1.1 days and 27.5 ± 1.2 days in the migraine and
healthy group, respectively. All the selected patients
experienced a migraine attack during the menstruation
following the recording session. LEP recording followed
the last attack from 72 to 124 h (90 ± 9.1 h); it preceded
the next attack ranged from 25 to 50 h in the pre-menstrual
phase (mean 33 ± 5.7 h) and from 50 to 180 h in the late
luteal phase. The occurrences of menstruation, as well as




Cutaneous heat stimuli were delivered by a CO2 laser
(wavelength 10.6 lm, 2 mm beam diameter—ELEN,
Florence, Italy) on the dorsum of the right hand and the right
supraorbital zone. We chose to limit the study to a right
sided stimulation in order to avoid a lengthy, uncomfortable
procedure and because none of the selected migraineurs
reported a higher attack prevalence on one side. The stim-
ulation site was visualized by a He–Ne laser beam. The
location of the impact on the skin was slightly shifted
between two successive stimuli, to avoid the sensitization of
the nociceptors. CO2 laser stimuli were delivered at a fixed
power of 7.5 W and duration of 25 ms [23], which was
perceived by all patients and controls as a painful pinprick.
We took attention to settle the laser power and duration at a
suprathreshold level in all cases [23], using a 10-point
verbal analog scale in which ‘0’ corresponds to no sensa-
tion, ‘4’ to the pain threshold and ‘10’ to intolerable pain. In
all patients and controls the 25 ms duration and 7.5 W
intensity laser stimuli were judged as a painful pinprick,
with a value[6 in more than 50% of 20 stimuli.
Patients and controls were examined in the ovulation
and pre-menstrual phases, stimulating in random order the
hand and facial zone. In order to assess habituation, three
consecutive series of 20 laser stimuli were delivered, with
and inter-stimulus interval (ISI) in the range of 10–15 s,
and an interval between the series of 5 min [18]. All sub-
jects were requested to take attention to the stimuli and to
count them. At the end of each stimulation series, they had
also to rate pain induced by laser. In order to assess pain
intensity, a 0–100-point VAS, in which ‘0’ corresponds to
no pain and ‘100’ to the worst pain one may conceive, was
used.
Recording
During LEPs recording, the subjects lay on a couch in a
warm and semi-dark room; they were awake and relaxed,
with eyes open. Both the subject and the experimenters
wore protective goggles or glasses during data acquisition.
LEPs were obtained using surface recording electrodes,
placed at Cz and Pz, referred to the nasion, and T3 and T4
positions, referred to Fz derivation (10–20 international
system), by means of MICROMED EEG apparatus
(Micromed Brain Quick, Mogliano Veneto, Italy). A fur-
ther electrode was positioned above the right eyebrow for
electro-oculogram (EOG) recording. The ground electrode
was at Fpz.
LEPs analysis
An investigator blind to the clinical condition and men-
strual phase analyzed the LEPs. They were analyzed for 1-s
with 100 ms pre-stimulus time at a sampling rate of
512 Hz, using the advanced source analysis (ASA) vers.
4.6 by ANT software. All runs containing transients
exceeding 65 lV at each recording channel were excluded
from the average by an automatic artifact rejection algo-
rithm. In addition, further artifacts were visually inspected
and an average of at least 15 artifact-free responses was
obtained off-line, for each stimulation series.
For each stimulation site, an average across the single
series of stimuli was obtained for the right hand and right
supra-orbital zone. LEPs were identified based on their
latency and distribution, and three responses were labeled
according to Valeriani et al. [24]. The N2a (namely N2)
and P2 components were analyzed at the vertex (Cz) and
the N1 component was analyzed at T3–Fz trace. Absolute
latencies of the scalp potentials were measured at the
highest peak of each response component and the ampli-
tude of each wave was measured from the baseline.
Baseline was measured automatically by calculating the
average signal on the whole sweep and subtracting it from
the trace (ASA-vers. 4.6 by ANT software). In addition, the
peak-to-peak amplitude was taken into consideration for
the vertex biphasic LEP component (N2–P2). All the
waves were identified in a time window compatible with
the mean latencies indicated by Cruccu et al. [25].
Statistical analysis
After the Kolmogorov–Smirnov statistic, with a Lilliefors
significance level, was applied for testing normality, the
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mean VAS values and the N1 and N2–P2 amplitudes and
latencies, computed across the three repetitions, were the
variables for a two-way ANOVA analysis, where the
diagnosis and the menstrual phase were the main factors. In
order to assess the outcome of LEP habituation in the
different phases, we computed the ratio between the N2–P2
amplitudes recorded in the third and in the first stimulation
series. The influence of diagnosis and menstrual phase was
evaluated, using a two-way ANOVA with diagnosis and




LEP latencies were not significantly modified in the two
phases across the two groups.
LEP amplitudes
Migraine patients exhibited enhanced N2 and P2 wave
amplitudes, with an increase of the N2–P2 complex, at the
hand level, and increased P2 and N2–P2 amplitudes, at the
trigeminal level, when compared with non migraine
women (Fig. 1; Table 1). In both groups, at the hand and
trigeminal levels, there was a significant increase of N2–P2
complex and P2 wave amplitudes in the pre-menstrual
phase (Figs. 1, 2; Table 1).
Pain rating
The laser pain, measured by 0–100 VAS, was also
increased in the pre-menstrual phase in both migraine and
control groups (Fig. 3; Table 1).
N2–P2 habituation
Considering the mean N2–P2 percent ratio of amplitude
variation between the third and the first repetition, com-
puted across the two phases, a reduced habituation was
present in migraine patients at both the hand (two-ways
ANOVA with group as factor F = 4.9, df 1, P 0.039) and
the face levels (two-ways ANOVA with group as factor
F = 5.63, df 1, P 0.027). Moreover, this ratio was further
reduced in both groups for the effect of phase at the hand
(two-ways ANOVA with phase as factor F = 4.95, df 1,
P 0.035; phase 9 group F = 0.012, P 0.78) and the
supraorbital zone level (phase as factor = 11.75, P 0.0025,
phase 9 group F = 1.2, P 0.47). In fact, the LEP vertex
complex habituation decreased in the premenstrual phase
in both patients and controls (Fig. 4).
Discussion
In this study we firstly confirmed previous findings about
LEPs in migraine. In fact, in migraineurs the average value
of N2–P2 amplitude habituation, computed across the two
phases, was reduced at both the hand and trigeminal level
[18, 20]. According to previous studies where repetitive
laser stimulations series were considered in patients and
controls [20], a global increase of the averaged LEPs
concurred with the phenomenon of reduced habituation.
Moreover, this study provided the first objective neu-
rophysiologic evidence about modifications of the brain
responses to painful stimuli across the menstrual phases in
normal and migraine women. Despite the low number of
enrolled subjects, an increase of pain perception emerged
during the pre-menstrual phase, as compared to the late
luteal phase, at both the hand and trigeminal levels, inde-
pendently from migraine diagnosis, confirming previous
results [12].
In line with the subjective pain rating, the cycle phase
modified also the LEP amplitudes in migraineurs and














































































































Fig. 1 Mean values and standard errors of laser evoked potentials
amplitude in migraine patients (no. 9) and controls (no. 10)
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controls. In fact, in both groups, the P2 wave increment
caused an amplitude increase of the N2–P2 complex in the
pre-menstrual phase. We can assume that the hormonal
fluctuations occurring during the pre-menstrual phase may
facilitate cortical responses to painful stimuli in both
women groups, thus showing a pro-nociceptive effect at
Table 1 Results of two way ANOVA applied to laser evoked potentials amplitudes and laser pain, considering the diagnosis, the menstrual
phase and the interaction between diagnosis and menstrual phases as the main factors
Hand Supraorbital zone
Diagnosis Menstrual phase Diagnosis 9 phase Diagnosis Menstrual phase Diagnosis 9 phase
N1
F 0.17 1.12 0.11 0.85 1.34 0.06
df 1 1 1 1 1 1
P 0.6 0.29 0.7 0.36 0.25 0.8
N2
F 15.78 0.63 0.085 1 1.34 1
df 1 1 1 1 1 1
P 0.0001 0.43 0.77 0.3 0.25 0.3
P2
F 18 10.32 1.87 8.99 5.8 0.09
df 1 1 1 1 1 1
P 0.0001 0.003 0.18 0.005 0.022 0.7
N2–P2
F 30.80 7.9 1.68 5.32 5.22 1.55
df 1 1 1 1 1 1
P 0.0001 0.008 0.2 0.027 0.029 0.22
VAS
F 2.47 22 2.48 1.13 6.84 0.03
df 1 1 1 1 1 1
P 0.25 0.0001 0.25 0.29 0.013 0.85
Fig. 2 Grand average of laser
evoked potentials across
patients and control, obtained
by the average of the three
consecutive series of laser
stimulation at 7.5 W intensity
and 25 ms stimuli duration. In
black: LEPs in the pre-
menstrual phase. In gray: LEPs
in the late luteal phase
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central level. The lack of a significant N1 and N2 ampli-
tude increment during the pre-menstrual phase in both
patients and controls may be caused by the low number of
cases, and deserves further evaluation, in order to confirm
the impression that the hormonal influence on the cortical
zones devoted to the pain processing is not homogenous.
Though our recording method did not enable a topographic
and dipolar source analysis of the LEP responses, the later
vertex complex changes, which seems to take origin from
the anterior cingulate cortex (ACC) [26], may confirm
functional magnetic resonance imaging (fMRI) findings,
showing an increased activity in the anterior part of the
anterior cingulate during the low-estrogen phase of the
cycle [27].
The subjective increase of pain rating, concurring with
enhanced activity of cortical areas devoted to noxious
stimuli elaboration, was independent of migraine diagno-
sis, and was present at the hand and trigeminal levels. The
correlation between pain in the head and menstrual cycle
has been recognized since Hippocrates [5] and may be a
direct effect of this phenomenon. It has been recently
suggested that also tension-type headache is more frequent
during the menstrual phase, so that the menstrual-related
tension-type headache may be a clinical entity [28].
In control women, the N2–P2 amplitude habituation
decreased during the pre-menstrual phase, as well as in
migraine patients. In migraine, the pattern of reduced
habituation to repetitive stimuli has been generally attrib-
uted to an abnormal cortical excitability [2]. In control
women, the neuro-transmission modifications linked to
estrogen and progesterone withdrawal [29] may cause
changes of the brain excitability that could become more
similar to the migraineur one. This hypothesis may also
explain the increased probability to develop a migraine
attack in the pre-menstrual phase in women with genetic
predisposition to migraine. Subjects with familiar risk of
migraine, showed reduced habituation of nociceptive blink
reflex as a sign of their susceptibility to develop migraine
under precipitating factors [30]. In migraine, high estrogen
levels may balance the abnormal neuronal excitability [31].
It has been previously suggested that, when estrogen levels
fall at menses, a mismatch in homeostatic gene regulation
by estrogen unmasks non-nuclear mitogen-activated hyper-
excitability of cell membranes, sensitizing neurons to
triggers that activate migraine attacks [31]. A previous
study on the CNV, an event related potential whose
amplitude and habituation abnormalities have been corre-
lated with cortical functional changes predisposing to
migraine [10], showed that during the pre-menstrual phase
both migraine patients and non migraine healthy women
exhibited a CNV amplitude increase [11]. The increased
amplitude and reduced habituation of LEPs in both
migraine and non migraine groups, occurring in the pre-
menstrual phase, may be due to a generic hormonal effect
on cortical excitability, not specific for nociceptive cortex.
Nevertheless, the increased activation of cortical areas
devoted to pain elaboration may be critical for migraine
attack occurrence [21].
The main limitations of the present study are represented
by: (1) the low number of subjects, and (2) the lack of an
objective measure of the hormonal levels in the follicular
and late lutenic phases.
Therefore, further studies are needed to confirm that the
estrogen withdrawal occurring during the menstrual cycle
may favor pro-nociceptive changes at cortical level. We
can suppose that this may be a factor precipitating pain
symptoms and migraine in predisposed women.
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Fig. 3 Mean values and standard errors of VAS values reporting the
subjective pain sensation by laser stimuli in migraine patients (no. 9)
and controls (no. 10)













Fig. 4 Mean values and standard errors of percent ratio of amplitude
variation, computed between the third and the first series of N2–P2
complexes, in migraine patients (no. 9) and controls (no. 10)
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